Connection

William Creasman to Time Factors

Back to Details
This is a "connection" page, showing publications William Creasman has written about Time Factors.
William Creasman
Connection Strength
0.092
Time Factors
  1. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. J Natl Cancer Inst. 2017 03 01; 109(3):1-10.
    View in: PubMed
    Score: 0.020
  2. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols. Obstet Gynecol. 1987 Feb; 69(2):151-5.
    View in: PubMed
    Score: 0.010
  3. Radical hysterectomy as therapy for early carcinoma of the cervix. Am J Obstet Gynecol. 1986 Nov; 155(5):964-9.
    View in: PubMed
    Score: 0.010
  4. A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group study. Am J Clin Oncol. 1984 Jun; 7(3):257-60.
    View in: PubMed
    Score: 0.008
  5. The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol. 1984 Apr 15; 148(8):1051-4.
    View in: PubMed
    Score: 0.008
  6. Stage II carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 1979 Mar; 5(3):323-6.
    View in: PubMed
    Score: 0.006
  7. Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study. Cancer Treat Rep. 1979 Feb; 63(2):319-23.
    View in: PubMed
    Score: 0.006
  8. A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Oct; 63(1):101-4.
    View in: PubMed
    Score: 0.005
  9. Preoperative evaluation of patients with recurrent carcinoma of the cervix. Gynecol Oncol. 1972 Nov; 1(1):111-8.
    View in: PubMed
    Score: 0.004
  10. Carcinoma in situ of the cervix. An analysis of 861 patients. Obstet Gynecol. 1972 Mar; 39(3):373-80.
    View in: PubMed
    Score: 0.003
  11. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991 Jan; 40(1):55-65.
    View in: PubMed
    Score: 0.003
  12. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study. Cancer. 1986 May 01; 57(9):1725-30.
    View in: PubMed
    Score: 0.002
  13. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol. 1986 Mar; 67(3):326-30.
    View in: PubMed
    Score: 0.002
  14. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study. Cancer Treat Rep. 1984 May; 68(5):809-11.
    View in: PubMed
    Score: 0.002
  15. Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol. 1980 May 01; 137(1):85-91.
    View in: PubMed
    Score: 0.002
  16. Treatment of cervical dysplasia with electrocautery and tetracycline suppositories. Am J Obstet Gynecol. 1973 Oct 15; 117(4):460-3.
    View in: PubMed
    Score: 0.001
  17. Treatment of metastatic trophoblastic disease: good and poor prognosis. Am J Obstet Gynecol. 1973 Feb 15; 115(4):451-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.